nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0815	0.114	CbGbCtD
Fluvoxamine—CYP3A7—Ifosfamide—germ cell cancer	0.0815	0.114	CbGbCtD
Fluvoxamine—CYP2B6—Ifosfamide—germ cell cancer	0.0776	0.109	CbGbCtD
Fluvoxamine—CYP3A5—Ifosfamide—germ cell cancer	0.0611	0.0859	CbGbCtD
Fluvoxamine—CYP2C19—Ifosfamide—germ cell cancer	0.0493	0.0693	CbGbCtD
Fluvoxamine—CYP2C9—Ifosfamide—germ cell cancer	0.041	0.0576	CbGbCtD
Fluvoxamine—CYP2B6—Cisplatin—germ cell cancer	0.0377	0.053	CbGbCtD
Fluvoxamine—CYP2E1—Etoposide—germ cell cancer	0.0376	0.0528	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—germ cell cancer	0.0337	0.0473	CbGbCtD
Fluvoxamine—CYP3A5—Etoposide—germ cell cancer	0.0292	0.041	CbGbCtD
Fluvoxamine—CYP3A4—Ifosfamide—germ cell cancer	0.0238	0.0335	CbGbCtD
Fluvoxamine—CYP1A2—Etoposide—germ cell cancer	0.0217	0.0305	CbGbCtD
Fluvoxamine—ABCB1—Vinblastine—germ cell cancer	0.0211	0.0297	CbGbCtD
Fluvoxamine—CYP2C9—Cisplatin—germ cell cancer	0.0199	0.028	CbGbCtD
Fluvoxamine—CYP2D6—Vinblastine—germ cell cancer	0.0199	0.0279	CbGbCtD
Fluvoxamine—ABCB1—Cisplatin—germ cell cancer	0.0193	0.0272	CbGbCtD
Fluvoxamine—ABCB1—Etoposide—germ cell cancer	0.019	0.0267	CbGbCtD
Fluvoxamine—CYP3A4—Vinblastine—germ cell cancer	0.0126	0.0178	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—germ cell cancer	0.0126	0.0177	CbGbCtD
Fluvoxamine—CYP3A4—Etoposide—germ cell cancer	0.0114	0.016	CbGbCtD
Fluvoxamine—CYP2C9—cardial valve—germ cell cancer	0.00774	0.135	CbGeAlD
Fluvoxamine—SLC6A3—telencephalic ventricle—germ cell cancer	0.0031	0.0542	CbGeAlD
Fluvoxamine—CYP2C19—urine—germ cell cancer	0.00215	0.0376	CbGeAlD
Fluvoxamine—SLC6A3—ganglion—germ cell cancer	0.00193	0.0338	CbGeAlD
Fluvoxamine—SLC6A4—ganglion—germ cell cancer	0.00177	0.0309	CbGeAlD
Fluvoxamine—CYP1A2—urine—germ cell cancer	0.00176	0.0307	CbGeAlD
Fluvoxamine—CYP2C9—urine—germ cell cancer	0.00167	0.0292	CbGeAlD
Fluvoxamine—CYP2E1—urine—germ cell cancer	0.00158	0.0276	CbGeAlD
Fluvoxamine—CYP1A1—skin epidermis—germ cell cancer	0.0014	0.0245	CbGeAlD
Fluvoxamine—CYP3A4—urine—germ cell cancer	0.00127	0.0222	CbGeAlD
Fluvoxamine—CYP2D6—urine—germ cell cancer	0.00125	0.0219	CbGeAlD
Fluvoxamine—SIGMAR1—trigeminal ganglion—germ cell cancer	0.000864	0.0151	CbGeAlD
Fluvoxamine—SLC6A3—brainstem—germ cell cancer	0.00084	0.0147	CbGeAlD
Fluvoxamine—CYP3A7—endocrine gland—germ cell cancer	0.000799	0.014	CbGeAlD
Fluvoxamine—SLC6A4—brainstem—germ cell cancer	0.00077	0.0134	CbGeAlD
Fluvoxamine—SLC6A3—telencephalon—germ cell cancer	0.000745	0.013	CbGeAlD
Fluvoxamine—SIGMAR1—eye—germ cell cancer	0.000744	0.013	CbGeAlD
Fluvoxamine—SLC6A4—telencephalon—germ cell cancer	0.000683	0.0119	CbGeAlD
Fluvoxamine—SIGMAR1—telencephalon—germ cell cancer	0.000678	0.0119	CbGeAlD
Fluvoxamine—SIGMAR1—decidua—germ cell cancer	0.000643	0.0112	CbGeAlD
Fluvoxamine—SIGMAR1—uterus—germ cell cancer	0.000562	0.00983	CbGeAlD
Fluvoxamine—SIGMAR1—pituitary gland—germ cell cancer	0.000552	0.00965	CbGeAlD
Fluvoxamine—SLC6A3—midbrain—germ cell cancer	0.000535	0.00935	CbGeAlD
Fluvoxamine—SIGMAR1—medulla oblongata—germ cell cancer	0.000533	0.00931	CbGeAlD
Fluvoxamine—SLC6A3—spinal cord—germ cell cancer	0.000522	0.00913	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal gland—germ cell cancer	0.000493	0.00862	CbGeAlD
Fluvoxamine—SLC6A4—midbrain—germ cell cancer	0.000491	0.00857	CbGeAlD
Fluvoxamine—ABCB1—blood vessel—germ cell cancer	0.000488	0.00853	CbGeAlD
Fluvoxamine—SIGMAR1—midbrain—germ cell cancer	0.000487	0.00851	CbGeAlD
Fluvoxamine—SLC6A4—spinal cord—germ cell cancer	0.000479	0.00836	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—germ cell cancer	0.000477	0.00834	CbGeAlD
Fluvoxamine—SIGMAR1—spinal cord—germ cell cancer	0.000475	0.00831	CbGeAlD
Fluvoxamine—SLC6A3—head—germ cell cancer	0.000464	0.00811	CbGeAlD
Fluvoxamine—SIGMAR1—female gonad—germ cell cancer	0.00046	0.00804	CbGeAlD
Fluvoxamine—SLC6A3—testis—germ cell cancer	0.000448	0.00784	CbGeAlD
Fluvoxamine—CYP1A1—skin of body—germ cell cancer	0.000435	0.0076	CbGeAlD
Fluvoxamine—SLC6A4—endocrine gland—germ cell cancer	0.000431	0.00753	CbGeAlD
Fluvoxamine—SLC6A4—head—germ cell cancer	0.000425	0.00743	CbGeAlD
Fluvoxamine—CYP2B6—skin of body—germ cell cancer	0.000423	0.00739	CbGeAlD
Fluvoxamine—CYP2E1—telencephalon—germ cell cancer	0.000416	0.00727	CbGeAlD
Fluvoxamine—SLC6A3—cerebellum—germ cell cancer	0.000414	0.00724	CbGeAlD
Fluvoxamine—SIGMAR1—testis—germ cell cancer	0.000408	0.00713	CbGeAlD
Fluvoxamine—CYP1A1—uterus—germ cell cancer	0.000378	0.00661	CbGeAlD
Fluvoxamine—SIGMAR1—cerebellum—germ cell cancer	0.000377	0.00659	CbGeAlD
Fluvoxamine—CYP2D6—brainstem—germ cell cancer	0.000371	0.00648	CbGeAlD
Fluvoxamine—CYP2B6—gonad—germ cell cancer	0.00037	0.00646	CbGeAlD
Fluvoxamine—CYP2C19—endocrine gland—germ cell cancer	0.000357	0.00624	CbGeAlD
Fluvoxamine—SLC6A3—brain—germ cell cancer	0.000336	0.00588	CbGeAlD
Fluvoxamine—CYP2D6—telencephalon—germ cell cancer	0.000329	0.00575	CbGeAlD
Fluvoxamine—CYP2E1—medulla oblongata—germ cell cancer	0.000327	0.00571	CbGeAlD
Fluvoxamine—CYP2B6—adrenal gland—germ cell cancer	0.000322	0.00563	CbGeAlD
Fluvoxamine—CYP1A1—female gonad—germ cell cancer	0.000309	0.0054	CbGeAlD
Fluvoxamine—SLC6A4—brain—germ cell cancer	0.000308	0.00539	CbGeAlD
Fluvoxamine—SIGMAR1—brain—germ cell cancer	0.000306	0.00535	CbGeAlD
Fluvoxamine—CYP2E1—adrenal gland—germ cell cancer	0.000302	0.00529	CbGeAlD
Fluvoxamine—CYP3A5—female gonad—germ cell cancer	0.000302	0.00528	CbGeAlD
Fluvoxamine—ABCB1—trigeminal ganglion—germ cell cancer	0.000302	0.00527	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—germ cell cancer	0.000296	0.00517	CbGeAlD
Fluvoxamine—CYP1A2—endocrine gland—germ cell cancer	0.000292	0.0051	CbGeAlD
Fluvoxamine—CYP2E1—spinal cord—germ cell cancer	0.000291	0.00509	CbGeAlD
Fluvoxamine—ABCB1—embryo—germ cell cancer	0.000291	0.00509	CbGeAlD
Fluvoxamine—CYP1A1—endocrine gland—germ cell cancer	0.000288	0.00503	CbGeAlD
Fluvoxamine—CYP1A1—head—germ cell cancer	0.000284	0.00496	CbGeAlD
Fluvoxamine—CYP3A5—endocrine gland—germ cell cancer	0.000281	0.00491	CbGeAlD
Fluvoxamine—CYP2B6—endocrine gland—germ cell cancer	0.00028	0.00488	CbGeAlD
Fluvoxamine—CYP2C9—endocrine gland—germ cell cancer	0.000277	0.00484	CbGeAlD
Fluvoxamine—CYP2B6—head—germ cell cancer	0.000276	0.00482	CbGeAlD
Fluvoxamine—CYP2B6—testis—germ cell cancer	0.000267	0.00466	CbGeAlD
Fluvoxamine—CYP2E1—endocrine gland—germ cell cancer	0.000262	0.00458	CbGeAlD
Fluvoxamine—CYP2E1—head—germ cell cancer	0.000259	0.00453	CbGeAlD
Fluvoxamine—ABCB1—retina—germ cell cancer	0.000257	0.0045	CbGeAlD
Fluvoxamine—Chest pain—Ifosfamide—germ cell cancer	0.000251	0.00109	CcSEcCtD
Fluvoxamine—Arthralgia—Ifosfamide—germ cell cancer	0.000251	0.00109	CcSEcCtD
Fluvoxamine—Myalgia—Ifosfamide—germ cell cancer	0.000251	0.00109	CcSEcCtD
Fluvoxamine—Renal failure acute—Methotrexate—germ cell cancer	0.000251	0.00108	CcSEcCtD
Fluvoxamine—Flatulence—Cisplatin—germ cell cancer	0.00025	0.00108	CcSEcCtD
Fluvoxamine—Anorexia—Dactinomycin—germ cell cancer	0.00025	0.00108	CcSEcCtD
Fluvoxamine—CYP2E1—testis—germ cell cancer	0.00025	0.00437	CbGeAlD
Fluvoxamine—Eye disorder—Etoposide—germ cell cancer	0.00025	0.00108	CcSEcCtD
Fluvoxamine—Cardiac disorder—Etoposide—germ cell cancer	0.000248	0.00107	CcSEcCtD
Fluvoxamine—Discomfort—Ifosfamide—germ cell cancer	0.000248	0.00107	CcSEcCtD
Fluvoxamine—Hypersensitivity—Vinblastine—germ cell cancer	0.000245	0.00106	CcSEcCtD
Fluvoxamine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000245	0.00106	CcSEcCtD
Fluvoxamine—Decreased appetite—Bleomycin—germ cell cancer	0.000245	0.00106	CcSEcCtD
Fluvoxamine—Visual disturbance—Methotrexate—germ cell cancer	0.000244	0.00106	CcSEcCtD
Fluvoxamine—Muscle spasms—Cisplatin—germ cell cancer	0.000244	0.00106	CcSEcCtD
Fluvoxamine—Angiopathy—Etoposide—germ cell cancer	0.000243	0.00105	CcSEcCtD
Fluvoxamine—Confusional state—Ifosfamide—germ cell cancer	0.000242	0.00105	CcSEcCtD
Fluvoxamine—Pain—Bleomycin—germ cell cancer	0.000241	0.00104	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00024	0.00104	CcSEcCtD
Fluvoxamine—Oedema—Ifosfamide—germ cell cancer	0.00024	0.00104	CcSEcCtD
Fluvoxamine—Chills—Etoposide—germ cell cancer	0.00024	0.00104	CcSEcCtD
Fluvoxamine—Vision blurred—Cisplatin—germ cell cancer	0.000239	0.00104	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000239	0.00103	CcSEcCtD
Fluvoxamine—Asthenia—Vinblastine—germ cell cancer	0.000239	0.00103	CcSEcCtD
Fluvoxamine—Infection—Ifosfamide—germ cell cancer	0.000239	0.00103	CcSEcCtD
Fluvoxamine—Tremor—Cisplatin—germ cell cancer	0.000238	0.00103	CcSEcCtD
Fluvoxamine—ABCB1—telencephalon—germ cell cancer	0.000237	0.00414	CbGeAlD
Fluvoxamine—Alopecia—Etoposide—germ cell cancer	0.000236	0.00102	CcSEcCtD
Fluvoxamine—Lethargy—Methotrexate—germ cell cancer	0.000236	0.00102	CcSEcCtD
Fluvoxamine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000236	0.00102	CcSEcCtD
Fluvoxamine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000236	0.00102	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000236	0.00102	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000235	0.00102	CcSEcCtD
Fluvoxamine—Anaemia—Cisplatin—germ cell cancer	0.000235	0.00102	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000232	0.00101	CcSEcCtD
Fluvoxamine—Feeling abnormal—Bleomycin—germ cell cancer	0.000232	0.001	CcSEcCtD
Fluvoxamine—Osteoarthritis—Methotrexate—germ cell cancer	0.000231	0.001	CcSEcCtD
Fluvoxamine—CYP2E1—cerebellum—germ cell cancer	0.000231	0.00404	CbGeAlD
Fluvoxamine—Anorexia—Ifosfamide—germ cell cancer	0.000229	0.000992	CcSEcCtD
Fluvoxamine—Malaise—Cisplatin—germ cell cancer	0.000229	0.000991	CcSEcCtD
Fluvoxamine—Decreased appetite—Dactinomycin—germ cell cancer	0.000228	0.000987	CcSEcCtD
Fluvoxamine—Diarrhoea—Vinblastine—germ cell cancer	0.000228	0.000986	CcSEcCtD
Fluvoxamine—Dysgeusia—Etoposide—germ cell cancer	0.000228	0.000986	CcSEcCtD
Fluvoxamine—Leukopenia—Cisplatin—germ cell cancer	0.000227	0.000984	CcSEcCtD
Fluvoxamine—Fatigue—Dactinomycin—germ cell cancer	0.000226	0.000979	CcSEcCtD
Fluvoxamine—Back pain—Etoposide—germ cell cancer	0.000225	0.000974	CcSEcCtD
Fluvoxamine—Hypotension—Ifosfamide—germ cell cancer	0.000225	0.000972	CcSEcCtD
Fluvoxamine—ABCB1—decidua—germ cell cancer	0.000225	0.00392	CbGeAlD
Fluvoxamine—Pain—Dactinomycin—germ cell cancer	0.000224	0.000971	CcSEcCtD
Fluvoxamine—Muscle spasms—Etoposide—germ cell cancer	0.000224	0.000968	CcSEcCtD
Fluvoxamine—Urticaria—Bleomycin—germ cell cancer	0.000224	0.000967	CcSEcCtD
Fluvoxamine—CYP2D6—female gonad—germ cell cancer	0.000223	0.0039	CbGeAlD
Fluvoxamine—Body temperature increased—Bleomycin—germ cell cancer	0.000222	0.000963	CcSEcCtD
Fluvoxamine—Irritability—Methotrexate—germ cell cancer	0.000221	0.000956	CcSEcCtD
Fluvoxamine—Dizziness—Vinblastine—germ cell cancer	0.00022	0.000953	CcSEcCtD
Fluvoxamine—Convulsion—Cisplatin—germ cell cancer	0.00022	0.000952	CcSEcCtD
Fluvoxamine—Mood swings—Methotrexate—germ cell cancer	0.000219	0.000949	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000219	0.000948	CcSEcCtD
Fluvoxamine—Ataxia—Methotrexate—germ cell cancer	0.000218	0.000942	CcSEcCtD
Fluvoxamine—Myalgia—Cisplatin—germ cell cancer	0.000216	0.000936	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000216	0.000936	CcSEcCtD
Fluvoxamine—Paraesthesia—Ifosfamide—germ cell cancer	0.000216	0.000934	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Etoposide—germ cell cancer	0.000216	0.000934	CcSEcCtD
Fluvoxamine—Anxiety—Cisplatin—germ cell cancer	0.000216	0.000933	CcSEcCtD
Fluvoxamine—Anaemia—Etoposide—germ cell cancer	0.000215	0.000931	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000215	0.000929	CcSEcCtD
Fluvoxamine—Dyspnoea—Ifosfamide—germ cell cancer	0.000214	0.000928	CcSEcCtD
Fluvoxamine—Somnolence—Ifosfamide—germ cell cancer	0.000214	0.000925	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000214	0.000925	CcSEcCtD
Fluvoxamine—Discomfort—Cisplatin—germ cell cancer	0.000214	0.000925	CcSEcCtD
Fluvoxamine—Vomiting—Vinblastine—germ cell cancer	0.000212	0.000917	CcSEcCtD
Fluvoxamine—CYP3A4—endocrine gland—germ cell cancer	0.000211	0.00369	CbGeAlD
Fluvoxamine—Malaise—Etoposide—germ cell cancer	0.00021	0.000908	CcSEcCtD
Fluvoxamine—Breast disorder—Methotrexate—germ cell cancer	0.000209	0.000905	CcSEcCtD
Fluvoxamine—Vertigo—Etoposide—germ cell cancer	0.000209	0.000905	CcSEcCtD
Fluvoxamine—Decreased appetite—Ifosfamide—germ cell cancer	0.000209	0.000905	CcSEcCtD
Fluvoxamine—Headache—Vinblastine—germ cell cancer	0.000209	0.000903	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000208	0.000902	CcSEcCtD
Fluvoxamine—Leukopenia—Etoposide—germ cell cancer	0.000208	0.000901	CcSEcCtD
Fluvoxamine—CYP2D6—endocrine gland—germ cell cancer	0.000208	0.00363	CbGeAlD
Fluvoxamine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000208	0.000898	CcSEcCtD
Fluvoxamine—Body temperature increased—Dactinomycin—germ cell cancer	0.000207	0.000898	CcSEcCtD
Fluvoxamine—Abdominal pain—Dactinomycin—germ cell cancer	0.000207	0.000898	CcSEcCtD
Fluvoxamine—Fatigue—Ifosfamide—germ cell cancer	0.000207	0.000897	CcSEcCtD
Fluvoxamine—Oedema—Cisplatin—germ cell cancer	0.000207	0.000897	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000207	0.000897	CcSEcCtD
Fluvoxamine—Hypersensitivity—Bleomycin—germ cell cancer	0.000207	0.000897	CcSEcCtD
Fluvoxamine—Infection—Cisplatin—germ cell cancer	0.000206	0.000891	CcSEcCtD
Fluvoxamine—CYP1A1—brain—germ cell cancer	0.000206	0.0036	CbGeAlD
Fluvoxamine—Pain—Ifosfamide—germ cell cancer	0.000206	0.00089	CcSEcCtD
Fluvoxamine—Constipation—Ifosfamide—germ cell cancer	0.000206	0.00089	CcSEcCtD
Fluvoxamine—CYP2D6—head—germ cell cancer	0.000205	0.00358	CbGeAlD
Fluvoxamine—Loss of consciousness—Etoposide—germ cell cancer	0.000205	0.000885	CcSEcCtD
Fluvoxamine—Nervous system disorder—Cisplatin—germ cell cancer	0.000203	0.00088	CcSEcCtD
Fluvoxamine—Cough—Etoposide—germ cell cancer	0.000203	0.000879	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000203	0.000878	CcSEcCtD
Fluvoxamine—Tachycardia—Cisplatin—germ cell cancer	0.000202	0.000876	CcSEcCtD
Fluvoxamine—Asthenia—Bleomycin—germ cell cancer	0.000202	0.000874	CcSEcCtD
Fluvoxamine—Convulsion—Etoposide—germ cell cancer	0.000202	0.000873	CcSEcCtD
Fluvoxamine—Hypertension—Etoposide—germ cell cancer	0.000201	0.000869	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Cisplatin—germ cell cancer	0.0002	0.000867	CcSEcCtD
Fluvoxamine—Asthma—Methotrexate—germ cell cancer	0.0002	0.000866	CcSEcCtD
Fluvoxamine—CYP2B6—brain—germ cell cancer	0.0002	0.00349	CbGeAlD
Fluvoxamine—Pruritus—Bleomycin—germ cell cancer	0.000199	0.000861	CcSEcCtD
Fluvoxamine—CYP1A1—lymph node—germ cell cancer	0.000199	0.00347	CbGeAlD
Fluvoxamine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000198	0.000858	CcSEcCtD
Fluvoxamine—Chest pain—Etoposide—germ cell cancer	0.000198	0.000857	CcSEcCtD
Fluvoxamine—CYP2D6—testis—germ cell cancer	0.000198	0.00346	CbGeAlD
Fluvoxamine—Nausea—Vinblastine—germ cell cancer	0.000198	0.000856	CcSEcCtD
Fluvoxamine—ABCB1—gonad—germ cell cancer	0.000198	0.00345	CbGeAlD
Fluvoxamine—Anorexia—Cisplatin—germ cell cancer	0.000198	0.000855	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000197	0.000851	CcSEcCtD
Fluvoxamine—ABCB1—uterus—germ cell cancer	0.000196	0.00343	CbGeAlD
Fluvoxamine—Pancreatitis—Methotrexate—germ cell cancer	0.000196	0.000849	CcSEcCtD
Fluvoxamine—Discomfort—Etoposide—germ cell cancer	0.000196	0.000847	CcSEcCtD
Fluvoxamine—Hypotension—Cisplatin—germ cell cancer	0.000194	0.000838	CcSEcCtD
Fluvoxamine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000193	0.000837	CcSEcCtD
Fluvoxamine—ABCB1—pituitary gland—germ cell cancer	0.000193	0.00337	CbGeAlD
Fluvoxamine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000192	0.00083	CcSEcCtD
Fluvoxamine—Confusional state—Etoposide—germ cell cancer	0.000192	0.000829	CcSEcCtD
Fluvoxamine—Urticaria—Ifosfamide—germ cell cancer	0.000191	0.000827	CcSEcCtD
Fluvoxamine—Body temperature increased—Ifosfamide—germ cell cancer	0.00019	0.000823	CcSEcCtD
Fluvoxamine—Abdominal pain—Ifosfamide—germ cell cancer	0.00019	0.000823	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Etoposide—germ cell cancer	0.00019	0.000822	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000189	0.000817	CcSEcCtD
Fluvoxamine—Infection—Etoposide—germ cell cancer	0.000189	0.000817	CcSEcCtD
Fluvoxamine—Asthenia—Dactinomycin—germ cell cancer	0.000188	0.000815	CcSEcCtD
Fluvoxamine—CYP2E1—brain—germ cell cancer	0.000188	0.00328	CbGeAlD
Fluvoxamine—Dysuria—Methotrexate—germ cell cancer	0.000187	0.00081	CcSEcCtD
Fluvoxamine—Paraesthesia—Cisplatin—germ cell cancer	0.000186	0.000806	CcSEcCtD
Fluvoxamine—ABCB1—medulla oblongata—germ cell cancer	0.000186	0.00325	CbGeAlD
Fluvoxamine—Thrombocytopenia—Etoposide—germ cell cancer	0.000186	0.000805	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000186	0.000805	CcSEcCtD
Fluvoxamine—Tachycardia—Etoposide—germ cell cancer	0.000185	0.000802	CcSEcCtD
Fluvoxamine—Dyspnoea—Cisplatin—germ cell cancer	0.000185	0.0008	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000184	0.000797	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Etoposide—germ cell cancer	0.000184	0.000795	CcSEcCtD
Fluvoxamine—CYP2D6—cerebellum—germ cell cancer	0.000183	0.0032	CbGeAlD
Fluvoxamine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000183	0.00079	CcSEcCtD
Fluvoxamine—Anorexia—Etoposide—germ cell cancer	0.000181	0.000783	CcSEcCtD
Fluvoxamine—Decreased appetite—Cisplatin—germ cell cancer	0.00018	0.00078	CcSEcCtD
Fluvoxamine—Diarrhoea—Dactinomycin—germ cell cancer	0.00018	0.000777	CcSEcCtD
Fluvoxamine—Pneumonia—Methotrexate—germ cell cancer	0.000179	0.000776	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000179	0.000775	CcSEcCtD
Fluvoxamine—Vomiting—Bleomycin—germ cell cancer	0.000179	0.000774	CcSEcCtD
Fluvoxamine—Drowsiness—Methotrexate—germ cell cancer	0.000178	0.000772	CcSEcCtD
Fluvoxamine—Depression—Methotrexate—germ cell cancer	0.000178	0.00077	CcSEcCtD
Fluvoxamine—Hypotension—Etoposide—germ cell cancer	0.000177	0.000768	CcSEcCtD
Fluvoxamine—Rash—Bleomycin—germ cell cancer	0.000177	0.000768	CcSEcCtD
Fluvoxamine—Pain—Cisplatin—germ cell cancer	0.000177	0.000767	CcSEcCtD
Fluvoxamine—Dermatitis—Bleomycin—germ cell cancer	0.000177	0.000767	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000177	0.000767	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000177	0.000765	CcSEcCtD
Fluvoxamine—Renal failure—Methotrexate—germ cell cancer	0.000175	0.000759	CcSEcCtD
Fluvoxamine—Stomatitis—Methotrexate—germ cell cancer	0.000174	0.000752	CcSEcCtD
Fluvoxamine—Conjunctivitis—Methotrexate—germ cell cancer	0.000173	0.00075	CcSEcCtD
Fluvoxamine—Asthenia—Ifosfamide—germ cell cancer	0.000173	0.000747	CcSEcCtD
Fluvoxamine—ABCB1—adrenal gland—germ cell cancer	0.000172	0.00301	CbGeAlD
Fluvoxamine—Sweating—Methotrexate—germ cell cancer	0.000171	0.00074	CcSEcCtD
Fluvoxamine—Feeling abnormal—Cisplatin—germ cell cancer	0.000171	0.000739	CcSEcCtD
Fluvoxamine—Paraesthesia—Etoposide—germ cell cancer	0.000171	0.000738	CcSEcCtD
Fluvoxamine—Pruritus—Ifosfamide—germ cell cancer	0.00017	0.000736	CcSEcCtD
Fluvoxamine—ABCB1—midbrain—germ cell cancer	0.00017	0.00297	CbGeAlD
Fluvoxamine—Haematuria—Methotrexate—germ cell cancer	0.00017	0.000736	CcSEcCtD
Fluvoxamine—Dyspnoea—Etoposide—germ cell cancer	0.000169	0.000733	CcSEcCtD
Fluvoxamine—Somnolence—Etoposide—germ cell cancer	0.000169	0.000731	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000169	0.00073	CcSEcCtD
Fluvoxamine—Epistaxis—Methotrexate—germ cell cancer	0.000168	0.000728	CcSEcCtD
Fluvoxamine—Nausea—Bleomycin—germ cell cancer	0.000167	0.000723	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—germ cell cancer	0.000167	0.000722	CcSEcCtD
Fluvoxamine—ABCB1—bone marrow—germ cell cancer	0.000167	0.00291	CbGeAlD
Fluvoxamine—Agranulocytosis—Methotrexate—germ cell cancer	0.000166	0.00072	CcSEcCtD
Fluvoxamine—ABCB1—spinal cord—germ cell cancer	0.000166	0.0029	CbGeAlD
Fluvoxamine—Rash—Dactinomycin—germ cell cancer	0.000165	0.000716	CcSEcCtD
Fluvoxamine—Decreased appetite—Etoposide—germ cell cancer	0.000165	0.000714	CcSEcCtD
Fluvoxamine—Diarrhoea—Ifosfamide—germ cell cancer	0.000165	0.000712	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000164	0.00071	CcSEcCtD
Fluvoxamine—Body temperature increased—Cisplatin—germ cell cancer	0.000164	0.000709	CcSEcCtD
Fluvoxamine—Fatigue—Etoposide—germ cell cancer	0.000164	0.000709	CcSEcCtD
Fluvoxamine—Pain—Etoposide—germ cell cancer	0.000162	0.000703	CcSEcCtD
Fluvoxamine—Constipation—Etoposide—germ cell cancer	0.000162	0.000703	CcSEcCtD
Fluvoxamine—Haemoglobin—Methotrexate—germ cell cancer	0.000161	0.000696	CcSEcCtD
Fluvoxamine—ABCB1—female gonad—germ cell cancer	0.000161	0.00281	CbGeAlD
Fluvoxamine—Haemorrhage—Methotrexate—germ cell cancer	0.00016	0.000693	CcSEcCtD
Fluvoxamine—Hepatitis—Methotrexate—germ cell cancer	0.00016	0.000693	CcSEcCtD
Fluvoxamine—Dizziness—Ifosfamide—germ cell cancer	0.000159	0.000688	CcSEcCtD
Fluvoxamine—Pharyngitis—Methotrexate—germ cell cancer	0.000159	0.000688	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000158	0.000684	CcSEcCtD
Fluvoxamine—Urethral disorder—Methotrexate—germ cell cancer	0.000157	0.000679	CcSEcCtD
Fluvoxamine—Feeling abnormal—Etoposide—germ cell cancer	0.000157	0.000677	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—germ cell cancer	0.000156	0.000675	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000155	0.000672	CcSEcCtD
Fluvoxamine—Visual impairment—Methotrexate—germ cell cancer	0.000154	0.000668	CcSEcCtD
Fluvoxamine—Vomiting—Ifosfamide—germ cell cancer	0.000153	0.000662	CcSEcCtD
Fluvoxamine—Hypersensitivity—Cisplatin—germ cell cancer	0.000153	0.000661	CcSEcCtD
Fluvoxamine—Rash—Ifosfamide—germ cell cancer	0.000152	0.000656	CcSEcCtD
Fluvoxamine—Dermatitis—Ifosfamide—germ cell cancer	0.000151	0.000656	CcSEcCtD
Fluvoxamine—Erythema multiforme—Methotrexate—germ cell cancer	0.000151	0.000655	CcSEcCtD
Fluvoxamine—Urticaria—Etoposide—germ cell cancer	0.000151	0.000653	CcSEcCtD
Fluvoxamine—Abdominal pain—Etoposide—germ cell cancer	0.00015	0.00065	CcSEcCtD
Fluvoxamine—Body temperature increased—Etoposide—germ cell cancer	0.00015	0.00065	CcSEcCtD
Fluvoxamine—Eye disorder—Methotrexate—germ cell cancer	0.00015	0.000648	CcSEcCtD
Fluvoxamine—ABCB1—endocrine gland—germ cell cancer	0.000149	0.00261	CbGeAlD
Fluvoxamine—Tinnitus—Methotrexate—germ cell cancer	0.000149	0.000646	CcSEcCtD
Fluvoxamine—Asthenia—Cisplatin—germ cell cancer	0.000149	0.000644	CcSEcCtD
Fluvoxamine—Cardiac disorder—Methotrexate—germ cell cancer	0.000149	0.000643	CcSEcCtD
Fluvoxamine—CYP2D6—brain—germ cell cancer	0.000149	0.0026	CbGeAlD
Fluvoxamine—ABCB1—head—germ cell cancer	0.000147	0.00258	CbGeAlD
Fluvoxamine—Angiopathy—Methotrexate—germ cell cancer	0.000145	0.000629	CcSEcCtD
Fluvoxamine—Chills—Methotrexate—germ cell cancer	0.000144	0.000622	CcSEcCtD
Fluvoxamine—Nausea—Ifosfamide—germ cell cancer	0.000143	0.000618	CcSEcCtD
Fluvoxamine—ABCB1—testis—germ cell cancer	0.000142	0.00249	CbGeAlD
Fluvoxamine—Diarrhoea—Cisplatin—germ cell cancer	0.000142	0.000614	CcSEcCtD
Fluvoxamine—Alopecia—Methotrexate—germ cell cancer	0.000142	0.000612	CcSEcCtD
Fluvoxamine—Mental disorder—Methotrexate—germ cell cancer	0.00014	0.000607	CcSEcCtD
Fluvoxamine—Hypersensitivity—Etoposide—germ cell cancer	0.00014	0.000606	CcSEcCtD
Fluvoxamine—Malnutrition—Methotrexate—germ cell cancer	0.000139	0.000603	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—germ cell cancer	0.000137	0.000591	CcSEcCtD
Fluvoxamine—Asthenia—Etoposide—germ cell cancer	0.000136	0.00059	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—germ cell cancer	0.000135	0.000584	CcSEcCtD
Fluvoxamine—Pruritus—Etoposide—germ cell cancer	0.000134	0.000582	CcSEcCtD
Fluvoxamine—Vomiting—Cisplatin—germ cell cancer	0.000132	0.00057	CcSEcCtD
Fluvoxamine—ABCB1—cerebellum—germ cell cancer	0.000132	0.0023	CbGeAlD
Fluvoxamine—Vision blurred—Methotrexate—germ cell cancer	0.000131	0.000569	CcSEcCtD
Fluvoxamine—Rash—Cisplatin—germ cell cancer	0.000131	0.000566	CcSEcCtD
Fluvoxamine—Dermatitis—Cisplatin—germ cell cancer	0.000131	0.000565	CcSEcCtD
Fluvoxamine—Diarrhoea—Etoposide—germ cell cancer	0.00013	0.000562	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000129	0.00056	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—germ cell cancer	0.000129	0.000558	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—germ cell cancer	0.000126	0.000544	CcSEcCtD
Fluvoxamine—Dizziness—Etoposide—germ cell cancer	0.000126	0.000544	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—germ cell cancer	0.000125	0.000542	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—germ cell cancer	0.000125	0.00054	CcSEcCtD
Fluvoxamine—Nausea—Cisplatin—germ cell cancer	0.000123	0.000533	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—germ cell cancer	0.000122	0.000526	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—germ cell cancer	0.000121	0.000523	CcSEcCtD
Fluvoxamine—Vomiting—Etoposide—germ cell cancer	0.000121	0.000523	CcSEcCtD
Fluvoxamine—Rash—Etoposide—germ cell cancer	0.00012	0.000518	CcSEcCtD
Fluvoxamine—Dermatitis—Etoposide—germ cell cancer	0.00012	0.000518	CcSEcCtD
Fluvoxamine—Headache—Etoposide—germ cell cancer	0.000119	0.000515	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—germ cell cancer	0.000119	0.000514	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—germ cell cancer	0.000119	0.000514	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—germ cell cancer	0.000119	0.000514	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—germ cell cancer	0.000117	0.000507	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—germ cell cancer	0.000115	0.000496	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000114	0.000492	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—germ cell cancer	0.000113	0.000489	CcSEcCtD
Fluvoxamine—Nausea—Etoposide—germ cell cancer	0.000113	0.000488	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—germ cell cancer	0.000112	0.000483	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000111	0.000482	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00011	0.000476	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—germ cell cancer	0.000108	0.000469	CcSEcCtD
Fluvoxamine—ABCB1—brain—germ cell cancer	0.000107	0.00187	CbGeAlD
Fluvoxamine—Hypotension—Methotrexate—germ cell cancer	0.000106	0.00046	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000104	0.000449	CcSEcCtD
Fluvoxamine—ABCB1—lymph node—germ cell cancer	0.000103	0.0018	CbGeAlD
Fluvoxamine—Insomnia—Methotrexate—germ cell cancer	0.000103	0.000445	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—germ cell cancer	0.000102	0.000442	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—germ cell cancer	0.000101	0.000439	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—germ cell cancer	0.000101	0.000438	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—germ cell cancer	0.0001	0.000433	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—germ cell cancer	9.89e-05	0.000428	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—germ cell cancer	9.82e-05	0.000425	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—germ cell cancer	9.81e-05	0.000424	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—germ cell cancer	9.73e-05	0.000421	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—germ cell cancer	9.38e-05	0.000406	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—germ cell cancer	9.3e-05	0.000403	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—germ cell cancer	9.04e-05	0.000391	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—germ cell cancer	8.99e-05	0.000389	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—germ cell cancer	8.99e-05	0.000389	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—germ cell cancer	8.38e-05	0.000363	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—germ cell cancer	8.16e-05	0.000353	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—germ cell cancer	8.05e-05	0.000348	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—germ cell cancer	7.78e-05	0.000337	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—germ cell cancer	7.52e-05	0.000326	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—germ cell cancer	7.23e-05	0.000313	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—germ cell cancer	7.17e-05	0.00031	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—germ cell cancer	7.17e-05	0.00031	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—germ cell cancer	7.13e-05	0.000308	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—germ cell cancer	6.76e-05	0.000292	CcSEcCtD
